• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 1044-1058 of 1,667 results

2108 Exhibit: Ex 2108 Brown DM, et al, Ranibizumab versus verteporfin for neovas...

Document IPR2022-01226, No. 2108-2 Exhibit - Ex 2108 Brown DM, et al, Ranibizumab versus verteporfin for neovascular age related macular degeneration (P.T.A.B. Apr. 5, 2023)

cite Cite Document
Analyze

1033 Exhibit: Ex 1033 Dix

Document IPR2022-01226, No. 1033 Exhibit - Ex 1033 Dix (P.T.A.B. Jul. 1, 2022)

cite Cite Document
Analyze

2270 Exhibit: Ex 2270 Yahoo Finance Beovu Now Publicly Reimbursed

Document IPR2022-01226, No. 2270-2 Exhibit - Ex 2270 Yahoo Finance Beovu Now Publicly Reimbursed (P.T.A.B. Apr. 5, 2023)

cite Cite Document
Analyze

1051 Exhibit: Ex 1051 Keane

Document IPR2022-01226, No. 1051 Exhibit - Ex 1051 Keane (P.T.A.B. Jul. 1, 2022)

cite Cite Document
Analyze

2202 Exhibit: Ex 2202 HCPCS Codes HCPCS Codes

Document IPR2022-01226, No. 2202-2 Exhibit - Ex 2202 HCPCS Codes HCPCS Codes (P.T.A.B. Apr. 5, 2023)

cite Cite Document
Analyze

1151 Exhibit: Ex 1151 US Statement of Facts 2 of 9

Document IPR2022-01226, No. 1151-2 Exhibit - Ex 1151 US Statement of Facts 2 of 9 (P.T.A.B. Jun. 29, 2023)

cite Cite Document
Analyze

1147 Exhibit: Ex 1147 Official EYLEA aflibercept Injection Website

Document IPR2022-01226, No. 1147 Exhibit - Ex 1147 Official EYLEA aflibercept Injection Website (P.T.A.B. Jun. 29, 2023)

cite Cite Document
Analyze

2192 Exhibit: Ex 2192 FiercePharma Beovu, Novartis

Document IPR2022-01226, No. 2192 Exhibit - Ex 2192 FiercePharma Beovu, Novartis (P.T.A.B. Apr. 5, 2023)

cite Cite Document
Analyze

2351 Exhibit: Ex 2351 Patent Owners Updated Demonstratives

Document IPR2022-01226, No. 2351 Exhibit - Ex 2351 Patent Owners Updated Demonstratives (P.T.A.B. Oct. 24, 2023)

cite Cite Document
Analyze

2029 Exhibit: Ex 2029 Robert Steinbrook, The Price of Sight — Ranibizumab, Bevaci...

Document IPR2022-01226, No. 2029 Exhibit - Ex 2029 Robert Steinbrook, The Price of Sight — Ranibizumab, Bevacizumab, and the Treatment of Macular Degeneration (P.T.A.B. Apr. 5, 2023)

cite Cite Document
Analyze

2014 Exhibit: Ex 2014 US Patent 7,303,748

Document IPR2022-01226, No. 2014 Exhibit - Ex 2014 US Patent 7,303,748 (P.T.A.B. Oct. 13, 2022)

cite Cite Document
Analyze

1081 Exhibit: Ex 1081 Hayes

Document IPR2022-01226, No. 1081 Exhibit - Ex 1081 Hayes (P.T.A.B. Jul. 1, 2022)

cite Cite Document
Analyze

2153 Exhibit: Ex 2153 Amgen Fusion Protein

Document IPR2022-01226, No. 2153 Exhibit - Ex 2153 Amgen Fusion Protein (P.T.A.B. Apr. 5, 2023)

cite Cite Document
Analyze

1123 Exhibit: Ex 1123 Eylea Patent List

Document IPR2022-01226, No. 1123 Exhibit - Ex 1123 Eylea Patent List (P.T.A.B. Jun. 29, 2023)

cite Cite Document
Analyze

2232 Exhibit: Ex 2232 Novartis Press Release June 11, 2020

Document IPR2022-01226, No. 2232 Exhibit - Ex 2232 Novartis Press Release June 11, 2020 (P.T.A.B. Apr. 5, 2023)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 70 71 72 73 74 ... >>